Hashimoto's thyroiditis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 30: Line 30:
*A family history of thyroid disorders is common, with HLA-B* 46:01 confers an increased risk of HT developing in Han Chinese children. The genes implicated vary in different groups and the incidence is increased in patients with chromosomal disorders, like[[Down syndrome|Down's]].
*A family history of thyroid disorders is common, with HLA-B* 46:01 confers an increased risk of HT developing in Han Chinese children. The genes implicated vary in different groups and the incidence is increased in patients with chromosomal disorders, like[[Down syndrome|Down's]].


=== Associated Conditions===
Hashimoto's disease may, in rare cases, be associated with other endocrine disorders caused by the immune system. Hashimoto's disease can occur with adrenal insufficiency and type 1 diabetes. In these cases, the condition is called type 2 polyglandular autoimmune syndrome (PGA II).
Less commonly, Hashimoto's disease occurs as part of a condition called type 1 polyglandular autoimmune syndrome (PGA I), along with:
* [[Adrenal insufficiency]]
* [[Fungal infection]]s of the mouth and nails
* [[Hypoparathyroidism]]


==References==
==References==

Revision as of 18:21, 17 July 2017

Hashimoto's thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hashimoto's Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hashimoto's thyroiditis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hashimoto's thyroiditis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hashimoto's thyroiditis pathophysiology

CDC on Hashimoto's thyroiditis pathophysiology

Hashimoto's thyroiditis pathophysiology in the news

Blogs on Hashimoto's thyroiditis pathophysiology

Directions to Hospitals Treating Hashimoto's thyroiditis

Risk calculators and risk factors for Hashimoto's thyroiditis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hashimoto's thyroiditis (HT) is characterized by Lymphocytic infiltration of the thyroid gland and production of antibodies that recognize thyroid-specific antigens.The pathogenesis is not yet completely understood. It is currently thought that the disease is caused by abnormalities in cellular and humoral immunity which results in a localized cell-mediated immune response directed toward the thyroid parenchymal cells. This results in the decreased production of thyroid hormones.

Pathophysiology

Cellular and humoral immunity is thought to be involved in the pathophysiology of Hashimoto's thyroiditis:[1]

Cellular immunity

  • Defects in T suppressor cell response to thyroid-specifc antigens in autoimmune hypothyroidism resulting in failure of T suppressor function.
  • Regulatory T cells like T suppressor cells also dampen the immune response. Regulatory T cells are high in CD25 expression and have altered activity in Hashimoto thyroiditis.
  • CD4+ cells are less sensitive to the inhibitory effect of TGFβ in Hashimoto thyroiditis.
  • There is an increased number of follicular helper T cells in patients Hashimoto's thyroiditis, which correlates with thyroid-specifc antibody levels.

Humoral immunity

  • Patients with Hashimoto thyroiditis have positive antibodies against thyroglobulin (TG) and Thyroid peroxidase (TPO).
  • Recently, a distinct variant of HT has been documented where the thyroid gland is infiltrated with IgG4-positive cells.
  • Thyroid hormone receptor antibodies might be involved in the disease presentation as sometimes thyroiditis presents as hyperthyroidism. The balance between the thyroid stimulating antibodies (TSAb) and thyroid blocking antibodies (TBAb) explains the fluctuating hormone levels in patients with Hashimoto's thyroiditis. It should also be noted that thyroid stimulating antibodies (TSAb) might have a minor blocking action.
  • The sodium iodide symporter (NIS) mediates iodine uptake by the thyroid gland, while pendrin is responsible for the efflux of iodine through thyroid follicles. Antibodies against NIS and pendrin are also found in Hashimoto thyroiditis (HT).

Cytokines

  • Increased plasma level and expressions of IL-17 and IL-22 are seen in HT.

Micro RNA

  • MicroRNAs (miRNA), which are small noncoding RNA regions, have also been implicated in the pathogenesis of thyroid immunity. In HT tissue, a decreased level of miR-155_2 and an increase in miR-200a1 was found.

Genetics

  • A family history of thyroid disorders is common, with HLA-B* 46:01 confers an increased risk of HT developing in Han Chinese children. The genes implicated vary in different groups and the incidence is increased in patients with chromosomal disorders, likeDown's.


References

  1. Ajjan RA, Weetman AP (2015). "The Pathogenesis of Hashimoto's Thyroiditis: Further Developments in our Understanding". Horm. Metab. Res. 47 (10): 702–10. doi:10.1055/s-0035-1548832. PMID 26361257.

Template:WH Template:WS